AXSM compared with GH: revenue, margins and what each company keeps, and the suppliers and customers both name

AXSMAxsome Therapeutics, Inc.

Mkt capRevenueRevenue

GHGuardant Health, Inc.

Mkt capRevenueRevenue

Compare

AXSMAxsome Therapeutics, Inc.

GHGuardant Health, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

AXSM

1 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±12.7%▼−5.83%×0.46

Q2 FY26±9.0%▲+3.83%×0.42

Q1 FY26±6.3%▲+8.31%×1.32

Feb 23 '26±7.1%▼−4.88%×0.69

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±12.9%▲+6.33%×0.49

Q1 FY26±11.8%▲+3.73%×0.31

= impliedAXSM realized, solidGH realized, hatchedOne scale, both sides: full bar = 13%× = |realized| ÷ impliedSource: market data

Feb 20 '26

±9.5%

▼−3.08%

×0.33

Jan 12 '26±7.4%▼−2.36%×0.32

AXSMAxsome Therapeutics, Inc.

135.90▼−5.91%· post 136.00· delayed

Mkt cap$7.6BRevenue$260MQ3 FY26Revenue$638MFY25

GHGuardant Health, Inc.

171.85▼−3.89%· post 170.00· delayed

After hoursNov 2 '26delayed

Mkt cap$22.9BRevenue$335MQ2 FY26Revenue$982MFY25

Compare

After hoursNov 2 '26delayed

AXSMAxsome Therapeutics, Inc.

GHGuardant Health, Inc.

135.90▼−5.91%post 136.00delayed

Price

171.85▼−3.89%post 170.00delayed

$7.6B

Mkt cap

$22.9B

Q3 FY26$260M

Revenue

$335MQ2 FY26

FY25$638M

Revenue

$982MFY25

AXSM135.90▼−5.91%vsGH171.85▼−3.89%After hoursNov 2 '26delayed